Study on clinical and clinical characteristics of cervical cancer with high risk hpv type
Main Article Content
Abstract
Cervical cancer is the second most common cancer in women, second to stomach cancer. Cervical cancer is 99% positive for HPV, of which over 70% encounter HPV types 16 and 18. The study aims to identify genetic variants of HPV to clarify the role of HPV. This cross - sectional descriptive study was 104 patients diagnosed for cervical cancer, HPV - positive (Cobas Test 4800): 51.9% were diagnosed with stage (0) cervical cancer; HPV type 16 infection accounts are highest at 55.8%, of which 41.4% have unusual symptoms such as profuse discharge or unusual vaginal bleeding. Squamous carcinoma accounts for 87.5%; With HPV 18 infection, 89.8% are adenocarcinoma. Colposcopy found 80.8% abnormality. In conclusion, cervical cancer has poor symptoms and low early detection rate. For early detection, HPV test is required.
Article Details
Keywords
Cervical cancer, clinical, subclinical, high - risk HPV type.
References
2. E. - M. De Villiers, C. Fauquet, T. R. Broker, H. - U. Bernard, and H. Zur Hausen, “Classification of papillomaviruses.,” Virology, vol. 324, no. 1, pp. 17 - 27, 2004.
3. A. F. Rositch, J. Koshiol, M. G. Hudgens, H. Razzaghi, D. M. Backes, J. M. Pimenta, E. L. Franco, C. Poole, and J. S. Smith, “Patterns of persistent genital human papillomavirus infection among women worldwide: A literature review and meta - analysis.,” Int. J. Cancer, pp. 1 - 15, Sep. 2012.
4. J. S. Smith, A. Melendy, R. K. Rana, and J. M. Pimenta, “Age - specific prevalence of infection with human papillomavirus in females: a global review.,” J. Adolesc. Health, vol. 43, no. 4 Suppl, pp. S5 - S25, S25.e1 - e41, 2008.
5. J. Ferlay, I. Soerjomataram, M. Ervik, R. Dikshit, S. Eser, C. Mathers, M. Rebelo, D. M. Parkin, D. Forman, and F. Bray, “GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase. No. 11 [Internet].,” Lyon, France: International Agency for Research on Cancer., 2013.
6. E. F. Dunne, E. R. Unger, M. Sternberg, G. McQuillan, D. C. Swan, S. S. Patel, and L. E. Markowitz, “Prevalence of HPV infection among females in the United States.,” JAMA, vol. 297, no. 8, pp. 813 - 9, Feb. 2007.
7. T. Q. Vinh, C. N. Thanh. Study on Human papiloma vius infection in women with precancerous lesions and cervical cancer, Journal of Practical Medicine, Ministry of Health, No. 718 - 719, tr, 229 - 240, 2010.
8. L. T. H. Vu and H. T. T. Le, “Cervical Human Papilloma Virus Infection among the General Female Population in Vietnam : A Situation Analysis,” vol. 12, pp. 561 - 566, 2011.
9. M. Cui, N. Chan, M. Liu, K. Thai, J. Malaczynska, I. Singh, D. Zhang, and F. Ye, “Clinical performance of roche Cobas 4800 HPV test,” J. Clin. Microbiol., vol. 52, no. 6, pp. 2210 - 2211, 2014.
10. E. Y. Ki, H. E. Kim, Y. J. Choi, J. S. Park, C. S. Kang, and A. Lee, “Comparison of the Cobas 4800 HPV test and the Seeplex HPV4A ACE with the hybrid capture 2 test,” Int. J. Med. Sci., vol. 10, no. 2, pp. 119 - 123, 2012.
11. P.V.Thanh, “The prevalence of HPV infection in people with an abnormal cervical smear” Report at the National Congres and the scientific conference of the Sixteenth Vietnam Association of Obstetríc and Gynecology, Ha Long City, pp. 103 - 110, 2009.
12. D. V. Khuong, “Research on histology, histology and some prognostic factors for cervical carcinoma”, Doctoral thesis of medicine, Hanoi, 2017.
13. L.D.Tam, “Study on the prevalence of Humam papiloma virus infection of some related factors and treatment results of cervical lesions in women in Can Tho city”. Doctoral thesis. Hue University, University of Medicine and Pharmacy, 2015.
14. Aanchal Jain, Balasubramaniam Ganesh, Saurabh C Bobdey, Jignasa A Sathwara, and Sushma Saoba, “Sociological and clinical profile of cervical cancer patient visiting a tertiary care hospital in India”, 2017.